These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 31105702)

  • 1. Human Double-Negative Regulatory T-Cells Induce a Metabolic and Functional Switch in Effector T-Cells by Suppressing mTOR Activity.
    Haug T; Aigner M; Peuser MM; Strobl CD; Hildner K; Mougiakakos D; Bruns H; Mackensen A; Völkl S
    Front Immunol; 2019; 10():883. PubMed ID: 31105702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-7 Abrogates the Immunosuppressive Function of Human Double-Negative T Cells by Activating Akt/mTOR Signaling.
    Allgäuer A; Schreiner E; Ferrazzi F; Ekici AB; Gerbitz A; Mackensen A; Völkl S
    J Immunol; 2015 Oct; 195(7):3139-48. PubMed ID: 26324773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Double-negative regulatory T cells induce allotolerance when expanded after allogeneic haematopoietic stem cell transplantation.
    McIver Z; Serio B; Dunbar A; O'Keefe CL; Powers J; Wlodarski M; Jin T; Sobecks R; Bolwell B; Maciejewski JP
    Br J Haematol; 2008 Apr; 141(2):170-8. PubMed ID: 18318770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the immunoregulatory function of human TCR-αβ+ CD4- CD8- double-negative T cells.
    Voelkl S; Gary R; Mackensen A
    Eur J Immunol; 2011 Mar; 41(3):739-48. PubMed ID: 21287552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of graft-versus-host disease by double-negative regulatory T cells.
    Young KJ; DuTemple B; Phillips MJ; Zhang L
    J Immunol; 2003 Jul; 171(1):134-41. PubMed ID: 12816991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Canine peripheral non-conventional TCRαβ
    Protschka M; Di Placido D; Moore PF; Büttner M; Alber G; Eschke M
    Front Immunol; 2024; 15():1400550. PubMed ID: 38835756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct Features of Canine Non-conventional CD4
    Rabiger FV; Rothe K; von Buttlar H; Bismarck D; Büttner M; Moore PF; Eschke M; Alber G
    Front Immunol; 2019; 10():2748. PubMed ID: 31824515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human CD8+ regulatory T cells inhibit GVHD and preserve general immunity in humanized mice.
    Zheng J; Liu Y; Liu Y; Liu M; Xiang Z; Lam KT; Lewis DB; Lau YL; Tu W
    Sci Transl Med; 2013 Jan; 5(168):168ra9. PubMed ID: 23325802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of CD3+CD4-CD8- T cells as potential regulatory cells in an experimental murine model of graft-versus-host skin disease (GVHD).
    Miyagawa F; Okiyama N; Villarroel V; Katz SI
    J Invest Dermatol; 2013 Nov; 133(11):2538-2545. PubMed ID: 23648548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of double-negative regulatory T cells in long-term cardiac xenograft survival.
    Chen W; Ford MS; Young KJ; Cybulsky MI; Zhang L
    J Immunol; 2003 Feb; 170(4):1846-53. PubMed ID: 12574350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Double negative Treg cells promote nonmyeloablative bone marrow chimerism by inducing T-cell clonal deletion and suppressing NK cell function.
    Su Y; Huang X; Wang S; Min WP; Yin Z; Jevnikar AM; Zhang ZX
    Eur J Immunol; 2012 May; 42(5):1216-25. PubMed ID: 22539294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Donor double-negative Treg promote allogeneic mixed chimerism and tolerance.
    He KM; Ma Y; Wang S; Min WP; Zhong R; Jevnikar A; Zhang ZX
    Eur J Immunol; 2007 Dec; 37(12):3455-66. PubMed ID: 18000953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blockade of Host β2-Adrenergic Receptor Enhances Graft-versus-Tumor Effect through Modulating APCs.
    Mohammadpour H; O'Neil R; Qiu J; McCarthy PL; Repasky EA; Cao X
    J Immunol; 2018 Apr; 200(7):2479-2488. PubMed ID: 29445008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A strategy to protect off-the-shelf cell therapy products using virus-specific T-cells engineered to eliminate alloreactive T-cells.
    Quach DH; Becerra-Dominguez L; Rouce RH; Rooney CM
    J Transl Med; 2019 Jul; 17(1):240. PubMed ID: 31340822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation and characterization of human antigen-specific TCR alpha beta+ CD4(-)CD8- double-negative regulatory T cells.
    Fischer K; Voelkl S; Heymann J; Przybylski GK; Mondal K; Laumer M; Kunz-Schughart L; Schmidt CA; Andreesen R; Mackensen A
    Blood; 2005 Apr; 105(7):2828-35. PubMed ID: 15572590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of the role of negative T cell costimulatory pathways in CD4 and CD8 T cell-mediated alloimmune responses in vivo.
    Ito T; Ueno T; Clarkson MR; Yuan X; Jurewicz MM; Yagita H; Azuma M; Sharpe AH; Auchincloss H; Sayegh MH; Najafian N
    J Immunol; 2005 Jun; 174(11):6648-56. PubMed ID: 15905503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infusion of ex-vivo expanded human TCR-αβ
    Achita P; Dervovic D; Ly D; Lee JB; Haug T; Joe B; Hirano N; Zhang L
    Clin Exp Immunol; 2018 Sep; 193(3):386-399. PubMed ID: 30066399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New differentiation pathway for double-negative regulatory T cells that regulates the magnitude of immune responses.
    Zhang D; Yang W; Degauque N; Tian Y; Mikita A; Zheng XX
    Blood; 2007 May; 109(9):4071-9. PubMed ID: 17197428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The accumulation of B220+ CD4- CD8- (DN) T cells in C3H-lpr/lpr mice is not accelerated by the stimulation of CD8+ T cells or B220+ DN T cells with staphylococcal enterotoxin B and occurs independently of V beta 8+ T cells.
    Giese T; Davidson WF
    Int Immunol; 1995 Aug; 7(8):1213-23. PubMed ID: 7495728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induced regulatory T cells promote tolerance when stabilized by rapamycin and IL-2 in vivo.
    Zhang P; Tey SK; Koyama M; Kuns RD; Olver SD; Lineburg KE; Lor M; Teal BE; Raffelt NC; Raju J; Leveque L; Markey KA; Varelias A; Clouston AD; Lane SW; MacDonald KP; Hill GR
    J Immunol; 2013 Nov; 191(10):5291-303. PubMed ID: 24123683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.